Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Human glucagon-like-peptide-1 mimics and their use in the treatment of diabetes and related conditions

Human glucagon-like-peptide-1 mimics and their use in the treatment of diabetes and related conditions

US Patent 7238671 · Granted Jul 3, 2007

Estimated economic value: $58,355,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Pyrimidinones as factor XIA inhibitors2025
Methods of treating kidney failure, and/or improving or stablizing renal functio2024
Treatment of fibrosis, cardiovascular disease and heart failure with modified re2024
Phosphorus (V)-based reagents, processes for the preparation thereof, and their 2024
Antibodies and antigen binding peptides for factor XIa inhibitors and uses there2024
Immunomodulators2024
Phosphorous (V)-based reagents, processes for the preparation thereof, and their2023
Modified relaxin polypeptides comprising a pharmacokinetic enhancer and pharmace2022
Immunomodulators2022
Antiseptic delivery device and method of use2022
Diazaspiro ROCK inhibitors2021
Method of treating cardiovascular disease and heart failure with modified relaxi2021